ZYXI Investors Called to Lead Charge in Zynex, Inc. Securities Fraud Case with the Schall Law Firm
Los Angeles, CA – Investors who have incurred losses from Zynex, Inc. are presented with the opportunity to potentially lead a collective lawsuit regarding alleged securities fraud. The Schall Law Firm, a nationally recognized shareholder rights litigation firm, is actively seeking participants who have faced financial damage from investments in the stock between February 26, 2021, and April 5, 2022. During this period, Zynex, Inc., a company known for manufacturing non-invasive medical devices for pain management and rehabilitation, is accused of providing misleading information to shareholders, directly impacting stock values. This includes optimistic revenue guidance … Read more